Alireza Ghasempour, Mohammad Amin Tokallou, Mohammad Reza Naderi Allaf, Mohsen Moradi, Hamideh Dehghan, Mahsa Sedighi, Mohammad-Ali Shahbazi, Fahimeh Lavi Arab
{"title":"Ferroptosis induction by engineered liposomes for enhanced tumor therapy.","authors":"Alireza Ghasempour, Mohammad Amin Tokallou, Mohammad Reza Naderi Allaf, Mohsen Moradi, Hamideh Dehghan, Mahsa Sedighi, Mohammad-Ali Shahbazi, Fahimeh Lavi Arab","doi":"10.3762/bjnano.16.97","DOIUrl":null,"url":null,"abstract":"<p><p>Ferroptosis has shown potential therapeutic effects in tumor therapy as an iron-dependent programmed cell death. The induction of ferroptosis is based on lipid peroxidation, the accumulation of iron and reactive oxygen species, and the depletion of glutathione. Nowadays, various nanoparticles are reported for ferroptosis-based therapy. Among them, engineered liposomes have received more attention due to their biocompatibility, low immunogenicity, and flexibility in chemical and structural modifications. The present review focuses on the mechanisms of ferroptosis and its induction by engineered liposomes to improve tumor therapy. It also highlights the fascinating outcome of liposome-mediated ferroptosis in overcoming the obstacles to cancer therapy, along with the limitations and possible future directions.</p>","PeriodicalId":8802,"journal":{"name":"Beilstein Journal of Nanotechnology","volume":"16 ","pages":"1325-1349"},"PeriodicalIF":2.7000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12362308/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Beilstein Journal of Nanotechnology","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.3762/bjnano.16.97","RegionNum":4,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MATERIALS SCIENCE, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Ferroptosis has shown potential therapeutic effects in tumor therapy as an iron-dependent programmed cell death. The induction of ferroptosis is based on lipid peroxidation, the accumulation of iron and reactive oxygen species, and the depletion of glutathione. Nowadays, various nanoparticles are reported for ferroptosis-based therapy. Among them, engineered liposomes have received more attention due to their biocompatibility, low immunogenicity, and flexibility in chemical and structural modifications. The present review focuses on the mechanisms of ferroptosis and its induction by engineered liposomes to improve tumor therapy. It also highlights the fascinating outcome of liposome-mediated ferroptosis in overcoming the obstacles to cancer therapy, along with the limitations and possible future directions.
期刊介绍：
The Beilstein Journal of Nanotechnology is an international, peer-reviewed, Open Access journal. It provides a unique platform for rapid publication without any charges (free for author and reader) – Platinum Open Access. The content is freely accessible 365 days a year to any user worldwide. Articles are available online immediately upon publication and are publicly archived in all major repositories. In addition, it provides a platform for publishing thematic issues (theme-based collections of articles) on topical issues in nanoscience and nanotechnology.
The journal is published and completely funded by the Beilstein-Institut, a non-profit foundation located in Frankfurt am Main, Germany. The editor-in-chief is Professor Thomas Schimmel – Karlsruhe Institute of Technology. He is supported by more than 20 associate editors who are responsible for a particular subject area within the scope of the journal.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
